President Trump Just Reclassified Marijuana. Are Green Thumb, Tilray, and Trulieve Stocks No-Brainer Buys?

• Trump's enforcement bid to reclassify marijuana from Schedule I to Schedule III recognized the valid aesculapian uses of the drug.

• The determination could interaction cannabis companies successful respective ways, including allowing them to deduct much concern expenses.

• Green Thumb, Tilray, and Trulieve volition beryllium helped by rescheduling marijuana, but investors should besides see different factors.

• 10 stocks we similar amended than Green Thumb Industries ›

Move speech April 20, besides known arsenic "420 Day." The cannabis manufacture present has a much important day to observe – Dec. 18.

Last Thursday, Dec. 18, 2025, President Donald Trump issued an enforcement bid calling for the reclassification of marijuana from a Schedule I classification to a Schedule III classification. Michael Bronstein, President of the American Trade Association for Cannabis and Hemp, called the determination "the astir important national displacement successful cannabis argumentation successful implicit 50 years."

As you mightiness expect, President Trump's determination has important implications for cannabis companies. But are 3 of the biggest marijuana stocks, Green Thumb Industries (OTC: GTBIF), Tilray Brands (NASDAQ: TLRY), and Trulieve Cannabis (OTC: TCNNF), present no-brainer buys?

Former President Richard Nixon signed the Controlled Substances Act into instrumentality successful 1970. It classified marijuana arsenic a Schedule I drug, which meant it was recovered to person "no presently accepted aesculapian usage and a precocious imaginable for abuse."

President Trump's caller enforcement bid directs Attorney General Pam Bondi to "take each indispensable steps" to reschedule marijuana to Schedule III. This docket is defined arsenic "drugs with a mean to debased imaginable for doc and intelligence dependence."

This enactment recognized that marijuana has morganatic aesculapian uses, making the Schedule I classification inappropriate. It besides reflected the world that 40 U.S. states, 3 territories, and the District of Columbia person legalized the usage of aesculapian cannabis.

Importantly, though, marijuana remains amerciable astatine the national level successful the U.S. Trump emphasized that his enforcement bid "doesn't legalize marijuana successful immoderate way, shape, oregon form, and successful nary mode sanctions its usage arsenic a recreational drug."

Green Thumb, Tilray, and Trulieve volition beryllium affected successful respective affirmative ways by the reclassification of marijuana. The CEOs of each 3 companies praised the Trump administration's decision.

Perhaps the astir captious interaction for Green Thumb, Tilray, and Trulieve is that they volition beryllium exempt from IRS Code Section 280E. This conception of the IRS codification prevents companies successful the cannabis manufacture from deducting immoderate concern expenses, including payroll and rent.